{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:09:19Z","timestamp":1761840559147,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R15DA049195-01A1"],"award-info":[{"award-number":["1R15DA049195-01A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 GM104944"],"award-info":[{"award-number":["U54 GM104944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.josat.2025.209695","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:49:38Z","timestamp":1744624178000},"page":"209695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["De-prescribing opioids among Medicaid patients with long-term opioid use"],"prefix":"10.1016","volume":"174","author":[{"given":"Sarah A.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Y.T.","family":"Hartzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209695_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: A nested case-control study","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2025.209695_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2025.209695_bb0015","unstructured":"Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths."},{"issue":"2","key":"10.1016\/j.josat.2025.209695_bb0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: Effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Annals of Palliative Medicine"},{"issue":"9","key":"10.1016\/j.josat.2025.209695_bb0025","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/j.1532-5415.2010.03015.x","article-title":"Risk of injury associated with opioid use in older adults","volume":"58","author":"Buckeridge","year":"2010","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.josat.2025.209695_bb0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/pds.2131","article-title":"Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort","volume":"20","author":"Carman","year":"2011","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"10.1016\/j.josat.2025.209695_bb0035","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: A systematic review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open"},{"issue":"3","key":"10.1016\/j.josat.2025.209695_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/M17-1402","article-title":"Changing the conversation about opioid tapering","volume":"167","author":"Dowell","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"15","key":"10.1016\/j.josat.2025.209695_bb0045","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2025.209695_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR - Recommendations and Reports"},{"issue":"10","key":"10.1016\/j.josat.2025.209695_bb0055","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Affairs (Millwood)"},{"issue":"4","key":"10.1016\/j.josat.2025.209695_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1208\/s12248-008-9056-1","article-title":"Opioid tolerance development: A pharmacokinetic\/pharmacodynamic perspective","volume":"10","author":"Dumas","year":"2008","journal-title":"The AAPS Journal"},{"issue":"12","key":"10.1016\/j.josat.2025.209695_bb0065","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ph14121279","article-title":"Opioid dosage levels, concurrent risk factors and self-perceptions among chronic pain, opioid-managed individuals at elevated risk for opioid overdose","volume":"14","author":"Ellis","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.josat.2025.209695_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008-2017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Network Open"},{"issue":"7","key":"10.1016\/j.josat.2025.209695_bb0075","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/pm\/pnaa470","article-title":"Longitudinal dose trajectory among patients tapering long-term opioids","volume":"22","author":"Fenton","year":"2021","journal-title":"Pain Medicine (Malden, Mass.)"},{"issue":"8","key":"10.1016\/j.josat.2025.209695_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28159","article-title":"Five-year trajectories of prescription opioid use","volume":"6","author":"Gisev","year":"2023","journal-title":"JAMA Network Open"},{"issue":"26","key":"10.1016\/j.josat.2025.209695_bb0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: Changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"S1","key":"10.1016\/j.josat.2025.209695_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1475-6773.13480","article-title":"Patient outcomes following opioid dose reduction among patients with chronic opioid therapy","volume":"55","author":"Hallvik","year":"2020","journal-title":"Health Services Research"},{"issue":"14","key":"10.1016\/j.josat.2025.209695_bb0105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209695_bb0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2147\/JPR.S308196","article-title":"Trajectories of opioid coverage after long-term opioid therapy initiation among a national cohort of US veterans","volume":"14","author":"Hayes","year":"2021","journal-title":"Journal of Pain Research"},{"issue":"3","key":"10.1016\/j.josat.2025.209695_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11606-023-08419-6","article-title":"Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study","volume":"39","author":"Henry","year":"2024","journal-title":"Journal of General Internal Medicine"},{"year":"2019","series-title":"HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics","key":"10.1016\/j.josat.2025.209695_bb0120"},{"issue":"2","key":"10.1016\/j.josat.2025.209695_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpain.2004.11.009","article-title":"Opioid tolerance and dependence \u2014 Do they matter?","volume":"9","author":"Jage","year":"2005","journal-title":"European Journal of Pain"},{"issue":"12","key":"10.1016\/j.josat.2025.209695_bb0135","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care\u2013based chronic opioid therapy for pain: A retrospective cohort study","volume":"34","author":"James","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2025.209695_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pmn.2010.02.001","article-title":"Risk factors for opioid-induced excessive respiratory depression","volume":"12","author":"Jungquist","year":"2011","journal-title":"Pain Management Nursing"},{"issue":"S3","key":"10.1016\/j.josat.2025.209695_bb0145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11606-020-06254-7","article-title":"Promoting patient-centeredness in opioid deprescribing: A blueprint for de-implementation science","volume":"35","author":"Kertesz","year":"2020","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209695_bb0150","first-page":"65","article-title":"Incidence of neonatal abstinence syndrome \u2014 28 states, 1999\u20132013","author":"Ko","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"11","key":"10.1016\/j.josat.2025.209695_bb0155","first-page":"2686","article-title":"\u201cThe lesser of two evils\u201d: A framework analysis of consumers\u2019 perspectives on opioid deprescribing and the development of opioid deprescribing guidelines","volume":"162","author":"Langford","year":"2021","journal-title":"Pain (Amsterdam)"},{"issue":"2","key":"10.1016\/j.josat.2025.209695_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","article-title":"Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: A qualitative analysis","volume":"30","author":"Langford","year":"2021","journal-title":"BMJ Quality and Safety"},{"year":"1986","series-title":"Longitudinal data analysis using generalized linear models","author":"Liang","key":"10.1016\/j.josat.2025.209695_bb0165"},{"key":"10.1016\/j.josat.2025.209695_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2024.03.018","article-title":"Impact of shared decision-making on opioid prescribing among patients with chronic pain: A retrospective cohort study","author":"Licciardone","year":"2024","journal-title":"The Journal of Pain"},{"issue":"1","key":"10.1016\/j.josat.2025.209695_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1353\/hpu.2015.0009","article-title":"Prescription practices involving opioid analgesics among Americans with Medicaid, 2010","volume":"26","author":"Mack","year":"2015","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.josat.2025.209695_bb0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events","volume":"103","author":"Mark","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209695_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/pm\/pnx038","article-title":"Risk factors for serious prescription opioid-induced respiratory depression or overdose: Comparison of commercially insured and veterans health affairs populations","volume":"19","author":"Nadpara","year":"2018","journal-title":"Pain Medicine"},{"author":"National Center for Injury Prevention and Control","key":"10.1016\/j.josat.2025.209695_bb0190"},{"key":"10.1016\/j.josat.2025.209695_bb0195","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/CLEP.S265287","article-title":"Trajectory modelling techniques useful to epidemiological research: A comparative narrative review of approaches","volume":"12","author":"Nguena Nguefack","year":"2020","journal-title":"Clinical Epidemiology"},{"author":"Office of the Inspector General","key":"10.1016\/j.josat.2025.209695_bb0200"},{"key":"10.1016\/j.josat.2025.209695_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: Observational evaluation","author":"Oliva","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.josat.2025.209695_bb0210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","article-title":"Opioid-induced bowel dysfunction: Prevalence, pathophysiology and burden","volume":"61","author":"Panchal","year":"2007","journal-title":"International Journal of Clinical Practice"},{"issue":"jun10 9","key":"10.1016\/j.josat.2025.209695_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.josat.2025.209695_bb0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11336-012-9248-6","article-title":"Predicting latent class scores for subsequent analysis","volume":"77","author":"Petersen","year":"2012","journal-title":"Psychometrika"},{"author":"Sugar","key":"10.1016\/j.josat.2025.209695_bb0225"},{"key":"10.1016\/j.josat.2025.209695_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107573","article-title":"Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status","volume":"204","author":"Tardelli","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"author":"U.S. Department of Justice Drug Enforcement Administration","key":"10.1016\/j.josat.2025.209695_bb0235"},{"issue":"4","key":"10.1016\/j.josat.2025.209695_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1377\/hlthaff.2016.1141","article-title":"States with prescription drug monitoring mandates saw a reduction in opioids prescribed to Medicaid enrollees","volume":"36","author":"Wen","year":"2017","journal-title":"Health Affairs (Millwood)"},{"issue":"11","key":"10.1016\/j.josat.2025.209695_bb0245","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/cid\/ciy809","article-title":"Long-acting opioid use and the risk of serious infections: A retrospective cohort study","volume":"68","author":"Wiese","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.josat.2025.209695_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12874-018-0584-9","article-title":"A systematic review of the clinical application of data-driven population segmentation analysis","volume":"18","author":"Yan","year":"2018","journal-title":"BMC Medical Research Methodology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:06:38Z","timestamp":1761840398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":47,"alternative-id":["S2949875925000748"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209695","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-prescribing opioids among Medicaid patients with long-term opioid use","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209695"}}